Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Oslo University Hospital
With
University of Oslo
Age
25–65
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
HIV seropositive \>4 years.
Continuous combined antiretroviral treatment (cART) \>4 years.
Plasma HIV RNA \<50 copies/mL \>3,5 years.
Cluster of differentiation(CD)4+ T cell count \<400 cells/µL (OR \>600 cells/µl) \>3.5 years.
Caucasian
Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to International Committee on Harmonization (ICH) Good Clinical Practice (GCP), and national/local regulations.
You may not be if
Plasma hepatitis C (HCV) RNA positive.
Serum hepatitis B surface antigen (HBsAg) positive.
Comorbidity of inflammatory bowel disease, coeliac disease or malnutrition.
Concomitant use of non-steroid anti-inflammatory drugs (NSAID), corticosteroids, disease-modifying antirheumatic drugs, or other anti-inflammatory pharmaceutical substances.
Concomitant use of antithrombotic pharmaceutical substances
Regular (weekly) use of any probiotic substance within 3 months prior to inclusion.
Use of antibiotics within 3 months prior to inclusion.
Deranged liver function (serum albumin \<25 g/L or Child-Pugh ≥10)
